source
- Experts discuss sequencing and patient selection for radiopharmaceuticals in advanced prostate cancerDr. Johann De Bono and Dr. Pedro Barata discuss how treatment sequencing is evolving for radiopharmaceuticals in metastatic castration-resistant prostate cancer. They highlight the need to match p…
- Choosing the Right Radiopharmaceuticals for Advanced Prostate CancerDr. Pedro Barata and Dr. Johann De Bono discuss how patient selection and disease characteristics affect the use of radiopharmaceuticals in metastatic castration‑resistant prostate cancer (mCRPC).…